Cargando…

Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles

BACKGROUND: This secondary analysis aimed to identify predictors of low (<6 oocytes retrieved) and high ovarian response (>18 oocytes retrieved) in IVF patients undergoing controlled ovarian stimulation with corifollitropin alfa in a gonadotropin-releasing hormone (GnRH) antagonist protocol. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oehninger, Sergio, Nelson, Scott M., Verweij, Pierre, Stegmann, Barbara J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628292/ https://www.ncbi.nlm.nih.gov/pubmed/26520396 http://dx.doi.org/10.1186/s12958-015-0113-1

Ejemplares similares

The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
por: Seyhan, Ayse, et al.
Publicado: (2011)

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol
por: Griesinger, Georg, et al.
Publicado: (2016)

Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity
por: Norman, Robert J., et al.
Publicado: (2011)

Estradiol pretreatment in GnRH antagonist protocol for IVF/ICSI treatment
por: Zhu, Shaomi, et al.
Publicado: (2022)

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
por: Alyasin, Ashraf, et al.
Publicado: (2016)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

Evaluation of GnRH antagonist pretreatment before ovarian stimulation in a GnRH antagonist protocol in normal ovulatory women undergoing IVF/ICSI: a randomized controlled trial
por: Zhang, Yisheng, et al.
Publicado: (2021)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
por: Youssef, M.A.F., et al.
Publicado: (2015)

A new approach for ovarian stimulation in IVF using Corifollitropin Alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot study
por: Decleer, W., et al.
Publicado: (2014)

Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction
por: Souza, Priscila Morais Galvão, et al.
Publicado: (2017)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
por: Lv, Mu, et al.
Publicado: (2022)

Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders
por: Errázuriz, Joaquín, et al.
Publicado: (2019)

GnRH Antagonist IVF Protocol in PCOS
por: Onofriescu, Alina, et al.
Publicado: (2013)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)

Corifollitropin stimulation in combination with GnRH-antagonists after estradiol valerate pre-treatment. A pilot study on patientfriendly IVF
por: Decleer, W, et al.
Publicado: (2015)

Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol
por: Huang, Ting-Chi, et al.
Publicado: (2021)

Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis
por: Kadoura, Sally, et al.
Publicado: (2022)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)

Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
por: Xing, Weijie, et al.
Publicado: (2015)

Comparison of Dydrogesterone and GnRH Antagonists for Prevention of Premature LH Surge in IVF/ICSI Cycles: A Randomized Controlled Trial
por: Hossein Rashidi, Batool, et al.
Publicado: (2020)

Evaluation of the safety and efficacy of corifollitropin alfa combined with GnRH agonist triggering in oocyte donation cycles. A prospective longitudinal study
por: Tsakiridis, Ioannis, et al.
Publicado: (2020)

Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis
por: Xiao, Jin-song, et al.
Publicado: (2014)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
por: Orvieto, Raoul, et al.
Publicado: (2020)

A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol
por: Devroey, P., et al.
Publicado: (2009)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
por: Kalafat, Erkan, et al.
Publicado: (2022)

Prolonged GnRH suppression period in controlled ovarian hyperstimulation cycles: Impacts on IVF outcomes?
por: Eryilmaz, Ozlem Gun, et al.
Publicado: (2012)

Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF
por: Zhang, Dan, et al.
Publicado: (2018)

Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study
por: Kaur, Harpreet, et al.
Publicado: (2012)

Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles
por: Vanni, V. S., et al.
Publicado: (2017)

A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF
por: Gordts, S., et al.
Publicado: (2012)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)

GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI
por: Kim, Chung-Hoon, et al.
Publicado: (2011)

Oxidative Stress Markers in GnRH Agonist and Antagonist Protocols in IVF
por: Tulić, Lidija, et al.
Publicado: (2017)

A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
por: Turgay Çelik, Gayem İnayet, et al.
Publicado: (2015)

Ovarian stimulation with GnRH analogues
por: Montenegro, Ivan S., et al.
Publicado: (2014)

Mild starting dosage ovarian stimulation combined with a modified prolonged GnRH-a protocol improved IVF/ICSI outcomes in normal ovarian responders
por: Tian, Li-Feng, et al.
Publicado: (2019)

Reassessing the feasibility of the zygote score for predicting embryo viability in IVF/ICSI using the GnRH antagonist protocol compared to the long protocol
por: Lin, Pin-Yao, et al.
Publicado: (2017)

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
por: Fusi, Francesco M., et al.
Publicado: (2019)

A prediction model for high ovarian response in the GnRH antagonist protocol
por: Jiang, Yilin, et al.
Publicado: (2023)

Cumulus Cells Gene Expression Profiling in Terms of Oocyte Maturity in Controlled Ovarian Hyperstimulation Using GnRH Agonist or GnRH Antagonist
por: Devjak, Rok, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pagbs2sum22iotb4vf3s7t75kb